X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9297) 9297
Book Review (1243) 1243
Publication (486) 486
Book / eBook (317) 317
Book Chapter (25) 25
Conference Proceeding (6) 6
Magazine Article (5) 5
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8554) 8554
humans (8474) 8474
male (5860) 5860
female (5241) 5241
aged (4773) 4773
middle aged (4632) 4632
urinary bladder neoplasms - pathology (3853) 3853
bladder cancer (3355) 3355
cancer (3350) 3350
urology & nephrology (3120) 3120
adult (2751) 2751
oncology (2524) 2524
aged, 80 and over (2435) 2435
prognosis (2174) 2174
urinary bladder neoplasms - surgery (1803) 1803
carcinoma (1685) 1685
tumors (1683) 1683
neoplasm staging (1573) 1573
carcinoma, transitional cell - pathology (1565) 1565
urology (1530) 1530
retrospective studies (1497) 1497
abridged index medicus (1367) 1367
urinary bladder neoplasms - genetics (1343) 1343
bladder (1326) 1326
urinary bladder neoplasms - mortality (1204) 1204
pathology (1192) 1192
analysis (1191) 1191
urinary bladder neoplasms - diagnosis (1180) 1180
urothelial carcinoma (1170) 1170
risk factors (1129) 1129
treatment outcome (1080) 1080
cystectomy (1078) 1078
urinary-bladder (1070) 1070
transitional-cell carcinoma (1069) 1069
survival (1067) 1067
diagnosis (1061) 1061
research (1059) 1059
care and treatment (991) 991
follow-up studies (989) 989
neoplasm invasiveness (973) 973
surgery (953) 953
immunohistochemistry (922) 922
urinary bladder (913) 913
urinary bladder neoplasms - metabolism (858) 858
radical cystectomy (853) 853
recurrence (842) 842
chemotherapy (793) 793
expression (785) 785
carcinoma, transitional cell - surgery (744) 744
urinary bladder neoplasms - therapy (740) 740
health aspects (701) 701
progression (697) 697
urinary bladder neoplasms - drug therapy (650) 650
survival rate (649) 649
medicine & public health (646) 646
animals (626) 626
disease progression (621) 621
bladder-cancer (618) 618
risk (614) 614
mortality (607) 607
time factors (606) 606
disease-free survival (592) 592
cystectomy - methods (585) 585
urinary bladder - pathology (578) 578
urinary bladder neoplasms - epidemiology (572) 572
carcinoma, transitional cell - mortality (569) 569
metastasis (566) 566
urothelium - pathology (555) 555
prospective studies (552) 552
urinary bladder neoplasms (549) 549
multivariate analysis (528) 528
development and progression (517) 517
urinary bladder neoplasms - classification (515) 515
classification (508) 508
transitional-cell-carcinoma (499) 499
medicine (476) 476
survival analysis (475) 475
oncology, experimental (457) 457
kaplan-meier estimate (453) 453
genetic aspects (448) 448
carcinoma, transitional cell - genetics (447) 447
proportional hazards models (445) 445
gene expression (439) 439
sensitivity and specificity (437) 437
patients (429) 429
gene expression regulation, neoplastic (428) 428
outcomes (417) 417
patient outcomes (415) 415
prostate cancer (413) 413
neoplasms (412) 412
cohort studies (410) 410
incidence (407) 407
therapy (401) 401
lymphatic metastasis (397) 397
complications (393) 393
neoplasm recurrence, local (385) 385
predictive value of tests (383) 383
bladder neoplasms (378) 378
radiotherapy (378) 378
urinary bladder neoplasms - urine (375) 375
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (268) 268
Collection Dvlpm't (Acquisitions) - Closed Orders (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Scarborough Hospital - General (6) 6
Holland Bloorview Kids Rehabilitation - Stacks (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Humber River Regional Hospital - Church Stacks (3) 3
Online Resources - Online (3) 3
Providence Healthcare - Reference (3) 3
St. Michael's Hospital - Stacks (3) 3
Toronto East General Hospital - Stacks (3) 3
Baycrest Hospital - Stacks (2) 2
Credit Valley Hospital - Reference (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Providence Healthcare - Stacks (2) 2
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Not Returned (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
Providence Healthcare - Reserve desk (1) 1
Scarborough Hospital - Birchmount (1) 1
Toronto East General Hospital - Online (1) 1
Trillium Health Centre - Stacks (1) 1
UofT Schools - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
West Park Healthcare Centre - Hospital Department (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9220) 9220
German (120) 120
French (103) 103
Japanese (57) 57
Spanish (57) 57
Chinese (15) 15
Italian (15) 15
Russian (14) 14
Danish (10) 10
Dutch (8) 8
Czech (7) 7
Polish (7) 7
Hungarian (4) 4
Turkish (3) 3
Croatian (2) 2
Hebrew (2) 2
Norwegian (2) 2
Arabic (1) 1
Bulgarian (1) 1
Korean (1) 1
Romanian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Pathology, ISSN 0022-3417, 05/2017, Volume 242, Issue 1, pp. 113 - 125
Journal Article
Cancer Cell, ISSN 1535-6108, 02/2014, Volume 25, Issue 2, pp. 152 - 165
Muscle-invasive bladder cancers (MIBCs) are biologically heterogeneous and have widely variable clinical outcomes and responses to conventional chemotherapy.... 
BREAST-CANCER | CELLS | ONCOLOGY | PROGNOSIS | UROTHELIAL CARCINOMA | RADICAL CYSTECTOMY | GENE-EXPRESSION | CLASSIFICATION | MICROARRAYS | P63 | PROGRESSION | CELL BIOLOGY | Receptors, Estrogen - metabolism | Urinary Bladder Neoplasms - classification | Cell Proliferation | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Muscle Neoplasms - pathology | Muscle Neoplasms - classification | Male | Gene Expression Profiling | Vinblastine - administration & dosage | PPAR gamma - metabolism | Receptor, Fibroblast Growth Factor, Type 3 - metabolism | Tumor Suppressor Protein p53 - genetics | Cisplatin - administration & dosage | Urinary Bladder Neoplasms - pathology | Female | Neoadjuvant Therapy | Cell Differentiation | Muscle Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Doxorubicin - administration & dosage | PPAR gamma - genetics | Receptor, Fibroblast Growth Factor, Type 3 - genetics | Receptors, Estrogen - genetics | Neoplasm Invasiveness | RNA, Messenger - genetics | Carcinoma, Basal Cell - pathology | Urinary Bladder Neoplasms - drug therapy | Mutation - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Drug Resistance, Neoplasm - genetics | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Basal Cell - drug therapy | Methotrexate - administration & dosage | Aged | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Neoplasm Staging | Clinical Trials, Phase II as Topic | Cohort Studies | Chemotherapy | Anthracyclines | Estrogen | Methotrexate | Tumor proteins | Bladder cancer | Cancer | Index Medicus
Journal Article
European Urology, ISSN 0302-2838, 2015, Volume 69, Issue 5, pp. 855 - 862
Abstract Background Gene expression profiling (GEP) suggests there are three subtypes of muscle-invasive urothelial cancer (UC): basal, which has the worst... 
Urology | Basal | Urothelial cancer | Dose-dense methotrexate cisplatin | Gene expression profiling | Luminal | Neoadjuvant | Subtype | Bevacizumab | p53 | METASTASIS | SUBTYPES | TUMORS | UROLOGY & NEPHROLOGY | CYSTECTOMY | CARCINOMA | INVASIVE BLADDER-CANCER | Urinary Bladder Neoplasms - classification | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Transcriptome | Bone Neoplasms - secondary | Male | Gene Expression Profiling | Vinblastine - administration & dosage | Tumor Suppressor Protein p53 - genetics | Cisplatin - administration & dosage | Urinary Bladder Neoplasms - genetics | Urinary Bladder Neoplasms - pathology | Adult | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Carcinoma, Transitional Cell - genetics | Doxorubicin - administration & dosage | Bevacizumab - administration & dosage | Proportional Hazards Models | Survival Rate | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Carcinoma, Transitional Cell - classification | Cystectomy | Carcinoma, Transitional Cell - drug therapy | Methotrexate - administration & dosage | Aged | Neoplasm Staging | Antimitotic agents | Anthracyclines | Patient outcomes | Adjuvant treatment | Product development | Genetic aspects | Tumor proteins | Antineoplastic agents | Gene expression | Cancer | Index Medicus | Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2012, Volume 18, Issue 12, pp. 3377 - 3386
Journal Article
American Journal of Pathology, The, ISSN 0002-9440, 2013, Volume 183, Issue 3, pp. 681 - 691
Journal Article
European Urology, ISSN 0302-2838, 2015, Volume 68, Issue 5, pp. 824 - 832
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2012, Volume 109, Issue 6, pp. 2078 - 2083
Journal Article
Journal Article
Journal Article